Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
2,938
2,938
2,519
1,568
1,022
958
Crecimiento de los Ingresos (YoY)
17%
17%
61%
53%
7%
21%
Costo de los ingresos
957
957
1,035
548
263
239
Utilidad bruta
1,981
1,981
1,484
1,020
759
718
Venta, General y Administración
1,178
1,178
977
643
432
408
Investigación y Desarrollo
146
146
161
124
73
97
Gastos de Operación
1,443
1,443
1,258
818
522
524
Otras Ingresos (Gastos) No Operativos
3
3
2
-2
1
0
Ingreso antes de impuestos
605
605
120
165
243
180
Gasto por Impuesto a la Renta
67
67
17
42
52
31
Ingreso Neto
537
537
102
122
190
149
Crecimiento de la Utilidad Neta
426%
426%
-16%
-36%
28%
46%
Acciones en Circulación (Diluidas)
136.56
137.05
137.86
114.63
102.6
103.6
Cambio de Acciones (YoY)
-2%
-1%
20%
12%
-1%
3%
EPS (Diluido)
3.93
3.92
0.74
1.07
1.85
1.44
Crecimiento de EPS
428%
425%
-30%
-42%
28%
43%
Flujo de efectivo libre
579
579
405
165
104
219
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
67.42%
67.42%
58.91%
65.05%
74.26%
74.94%
Margen de operación
18.27%
18.27%
8.93%
12.81%
23.09%
20.25%
Margen de beneficio
18.27%
18.27%
4.04%
7.78%
18.59%
15.55%
Margen de flujo de caja libre
19.7%
19.7%
16.07%
10.52%
10.17%
22.86%
EBITDA
655
813
479
345
304
263
Margen de EBITDA
22.29%
27.67%
19.01%
22%
29.74%
27.45%
D&A para EBITDA
118
276
254
144
68
69
EBIT
537
537
225
201
236
194
Margen de EBIT
18.27%
18.27%
8.93%
12.81%
23.09%
20.25%
Tasa de Impuesto Efectiva
11.07%
11.07%
14.16%
25.45%
21.39%
17.22%
Follow-Up Questions
Globus Medical Inc 的关键财务报表是什么?
根据最新的财务报表(Form-10K),Globus Medical Inc 的总资产为 $5,302,净ganancia为 $537
GMED 的关键财务比率是什么?
Globus Medical Inc 的流动比率是 7.27,净利 margin 为 18.27,每股销售为 $21.43。
Globus Medical Inc 的收入按细分市场或地理位置如何划分?
El segmento de ingresos más grande es Globus Medical Inc, con unos ingresos de Musculoskeletal Solutions en el último informe de ganancias. En cuanto a la geografía, United States es el mercado principal para Globus Medical Inc, con unos ingresos de 2,367,596,000.